ADHD medications offer promise in managing menopausal brain fog

An estimated 44% to 60% of perimenopausal women study cognitive changes similar forgetfulness and occupation concentrating—also known arsenic encephalon fog. Despite the effect of these symptoms connected prime of beingness and productivity, determination is presently nary FDA-approved pharmacological intervention.